Journal of Stroke10.5853/jos.2013.15.2.1152013152115VKORC1 and CYP2C9 Genotype Variations in Relation to Warfarin Dosing in Korean Stroke PatientsSea Mi Park, Jong-Keuk Lee, Sa Il Chun, Hae In Lee, Sun U. Kwon, Dong-Wha Kang, Jong S. Kim,,
Journal of Clinical Pharmacy and Therapeutics10.1111/jcpt.133342020463640-648A network meta‐analysis of CYP2C9 , CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype‐based warfarin dosing strategies compared to traditionalKannan Sridharan, Gowri Sivaramakrishnan,,
Laboratory Medicine10.1093/labmed/lmx072201749125-34Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene PolymorphismsNegin Farzamikia, Ebrahim Sakhinia, Abbas Afrasiabirad
European Journal of Clinical Pharmacology10.1007/s00228-007-0381-6200763121135-1141Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patientsLiyan Miao, Jian Yang, Chenrong Huang, Zhenya Shen,,
Clinical Therapeutics10.1016/j.clinthera.2016.10.014201638122666-2674.e1Evaluation of 16 genotype-guided Warfarin Dosing Algorithms in 310 Korean Patients Receiving Warfarin Treatment: Poor Prediction Performance in VKORC1 1173C CarriersMina Yang, Rihwa Choi, June Soo Kim, Young Keun On, Oh Young Bang, Hyun-Jung Cho, Soo-Youn Lee,
Chest10.1016/j.chest.2016.02.54120161494A519A Randomized Controlled Study of the VKORC1 and CYP2C9 Genotypes in Guiding Warfarin Initial Dosing Algorithm for Pulmonary ThromboembolismLinli Duan, Nuofu Zhang, Chunli Liu,
International Journal of Laboratory Hematology10.1111/j.1751-553x.2012.01426.x2012345517-524Frequency of VKORC1 (C1173T) and CYP2C9 genetic polymorphisms in Egyptians and their influence on warfarin maintenance dose: proposal for a new dosing regimenM. S. EL DIN, D. G. AMIN, S. B. RAGAB, E. E. ASHOUR, M. H. MOHAMED, A. M. MOHAMED
Clinical Chemistry10.1373/clinchem.2008.1184972009554823-826A Multiplex Assay for Detecting Genetic Variations in CYP2C9, VKORC1, and GGCX Involved in Warfarin MetabolismAlex J Rai, Nitin Udar, Rana Saad, Martin Fleisher,
Yearbook of Pathology and Laboratory Medicine10.1016/s1077-9108(09)79385-520102010354-356A Multiplex Assay for Detecting Genetic Variations in CYP2C9, VKORC1, and GGCX Involved in Warfarin MetabolismM.G. Bissell,
Case Reports in Genetics10.1155/2014/413743201420141-4Warfarin Dosing in a Patient withCYP2C9*3*3andVKORC1-1639 AAGenotypesMark Johnson, Craig Richard, Renee Bogdan, Robert Kidd,,